Quality by Design for Biopharmaceutical Drug Product Development

Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Jameel, Feroz. (Editor), Hershenson, Susan. (Editor), Khan, Mansoor A. (Editor), Martin-Moe, Sheryl. (Editor)
Format: eBook
Language:English
Published: New York, NY : Springer New York : Imprint: Springer, 2015.
Edition:1st ed. 2015.
Series:AAPS Advances in the Pharmaceutical Sciences Series, 18
Subjects:
Online Access:https://doi.org/10.1007/978-1-4939-2316-8
Table of Contents:
  • 1 Challenges and Opportunities for Biotech Quality by Design
  • 2 Lessons Learned From Monoclonal Antibody Applications to the Office of Biotechnology Products Quality by Design Pilot Program
  • 3 Definitions and Scope of Key Elements of QbD
  • 4 An Overview of Quality by Design for Drug Product
  • 5 Development of Drug Product Formulations: Molecular Design and Early Candidates Screening
  • 6 Approaches for Early Developability Assessment of Proteins to Guide Quality by Design of Liquid Formulations
  • 7 Application of QbD Principles to Late-stage Formulation Development for Biological Liquid Products
  • 8 Application of QbD Principles for Lyophilized Formulation Development
  • 9 Drug Substance Frozen Storage and Thawing
  • 10 Quality by Design as Applied to Drug Substance Formulation using Ultrafiltration and Diafiltration
  • 11 A QbD Approach in the Development and Scale-up of Mixing Processes
  • 12 Application of QbD Elements in the Development and Scale-up of a Commercial Filtration Process
  • 13 Application of QbD Elements in the Development and Scale-up of Commercial Filling Process
  • 14 Lyophilization Process Design and Development Using QbD Principles
  • 15 Visible and Subvisible Protein Particle Inspection Within a QbD-based Strategy
  • 16 Quality by Design for Distribution of Environmentally Sensitive Pharmaceutical Products
  • 17 Quality by Design for Primary Container Components
  • 18 Devices and Combination Products for Biopharmaceuticals
  • 19 Applicability of QbD for Vaccine Drug Product Development
  • 20 Automation and High Throughput Technologies in Biopharmaceutical Drug Product Development with QbD Approaches
  • 21 Critical Quality Attributes, Specifications, and Control Strategy
  • 22 Multivariate Analysis for Process Understanding, Monitoring, Control and Optimization in Lyophilization Processes
  • 23 Using Mathematical Modeling and Prior Knowledge for QbD in Freeze-drying Processes
  • 24 Application of Multivariate Statistical Process Monitoring to Lyophilization Process
  • 25 Application of PAT in Real-time Monitoring and Controlling of Lyophilization Process
  • 26 Product Homogeneity Assessment during Validation of Biopharmaceutical Drug Product Manufacturing Processes
  • 27 Application of Quality by Design Principles to the Drug Product Technology Transfer Process
  • 28 Regulatory Considerations For Implementation of the QbD Paradigm for Biologics: Laying the Foundation for Product and Process Lifecycle Management.